Form 4: CAH Insider Jason Hollar Disposes of 35,901 Shares on 08/20/2025

Rhea-AI Filing Summary

Insider transactions reported for Cardinal Health, Inc. (CAH). The Form 4 shows Jason M. Hollar, listed as Chief Executive Officer and an officer reporting person, sold common shares on 08/20/2025 in two separate sets of transactions. The first sale disposed of 12,944 shares at a weighted average price of $149.40, leaving 222,957 shares beneficially owned. The second sale disposed of 22,957 shares at a weighted average price of $150.40, leaving 200,000 shares beneficially owned following that reported transaction.

The filings note the prices are weighted averages from multiple trades within specified ranges and state the reporting person will provide further breakdowns on request. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• None.

Negative

• Insider sales disclosed: CEO sold a total of 35,901 shares on 08/20/2025 across reported transactions
• Reduction in beneficial ownership: Reported beneficial holdings decreased to 222,957 and 200,000 shares following the respective sales

Insights

Corporate Governance Expert

TL;DR: CEO Jason Hollar reported contemporaneous sales of common stock on 08/20/2025, disclosed as weighted-average multi-trade transactions.

The Form 4 is a routine Section 16 disclosure showing stock dispositions by the reporting officer rather than acquisitions. The report provides exact share counts sold (12,944 and 22,957) and weighted average prices ($149.40 and $150.40), plus post-transaction beneficial ownership figures (222,957 and 200,000). The filing includes standard footnotes indicating multiple trade prices and an offer to supply granular price-by-price breakdowns to the company, security holders, or the SEC staff.

Securities Analyst

TL;DR: Insider selling recorded; the disclosure is factual and compliant, showing volumes and weighted prices for multiple trades.

This Form 4 documents dispositions by an officer with explicit transaction dates and weighted-average pricing ranges. It follows required reporting format and includes an attorney-in-fact signature. The filing does not state the reason for the sales, any planned trading arrangement, or changes in compensation or ownership policy.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hollar Jason M.

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OH 43017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/20/2025		S		12,944	D	$149.4(1)	222,957	D
Common Shares	08/20/2025		S		22,957	D	$150.4(2)	200,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.85, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.94 to $150.80, inclusive.

Remarks:

	/s/ James E. Barnett, Attorney-in-fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jason M. Hollar report on the Form 4 for CAH?

The Form 4 reports that Jason M. Hollar sold 12,944 shares at a weighted average price of $149.40 and 22,957 shares at a weighted average price of $150.40 on 08/20/2025.

How many shares does the Form 4 show were owned after the transactions?

The filing shows beneficial ownership figures of 222,957 and 200,000 shares following the reported transactions.

Were the sale prices single trades or averaged?

The filing states the prices reported are weighted average prices from multiple transactions with specified price ranges provided in footnotes.

Does the Form 4 explain why the shares were sold?

No. The Form 4 does not state reasons for the dispositions or reference a Rule 10b5-1 trading plan in the checked boxes.

Who signed the Form 4?

The Form 4 was signed on behalf of the reporting person by James E. Barnett, Attorney-in-fact on 08/20/2025.